Repression of Thbs2 was accompanied by downregulation of fibrosis-associated proteins, including α-SMA, Fn, and collagen I. Our study is the first to identify that Thbs2 may be a potential target in the treatment of pulmonary fibrosis. Here, ACTA1 is linked to pulmonary fibrosis.